<DOC>
	<DOCNO>NCT02339896</DOCNO>
	<brief_summary>To determine Immunogenicity Safety Study Modified TRC-ID Regimen A New Chromatographically Purified Vero Cell Rabies Vaccine ( SPEEDAÂ® ) post exposure rabies intradermal regimen without Rabies Immunoglobulin Children</brief_summary>
	<brief_title>Observation Study Immunogenicity Modified TRC-ID Regimen With CPRV With Without Rabies Immunoglobulin Children</brief_title>
	<detailed_description>post exposure rabies vaccination modify Thai red cross intrademal regimen proven immunogenic effection use purified vero cell vaccine ( PVRV ) In present , new chromatographically purify vero cell rabies vaccine ( SPEEDA ) , chromatography purifed vero cell derive rabies vaccine , manufacture Liaoning Chengda Biotechnology available This study goal determine immunogenicity speeda use post exposure rabies intradermal vaccination without rabies immune globulin child</detailed_description>
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>115 year healthy child give sign informed consent parent willing participate study able receive vaccination collect blood sample study plan . prior history rabies vaccination equine/human serum administration snake antivenom tetanus antiserum vaccine allergy Persons immunosuppressive condition know HIV infection , transplantation , chronic renal failure , receive steroid immunosuppressive drug person receive antimalarial drug within previous two month blood product within previous three month exclude Urine pregnancy test must do female adolescent exclude pregnancy first visit</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>rabies</keyword>
	<keyword>modify TRC intradermal rabies vaccine</keyword>
	<keyword>SPEEDA</keyword>
</DOC>